These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36229930)

  • 1. SPARC expression in tumor microenvironment induces partial epithelial-to-mesenchymal transition of esophageal adenocarcinoma cells via cooperating with TGF-β signaling.
    Ma W; Yan Y; Bai S; Zhou Y; Wang X; Feng Z; Li G; Zhou S; Zhang J; Ren J
    Cell Biol Int; 2023 Jan; 47(1):250-259. PubMed ID: 36229930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel molecular pathway for Snail-dependent, SPARC-mediated invasion in non-small cell lung cancer pathogenesis.
    Grant JL; Fishbein MC; Hong LS; Krysan K; Minna JD; Shay JW; Walser TC; Dubinett SM
    Cancer Prev Res (Phila); 2014 Jan; 7(1):150-60. PubMed ID: 24253315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPARC acts as a mediator of TGF-β1 in promoting epithelial-to-mesenchymal transition in A549 and H1299 lung cancer cells.
    Sun W; Feng J; Yi Q; Xu X; Chen Y; Tang L
    Biofactors; 2018 Sep; 44(5):453-464. PubMed ID: 30346081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Esophageal Adenocarcinoma Cells and Xenograft Tumors Exposed to Erb-b2 Receptor Tyrosine Kinase 2 and 3 Inhibitors Activate Transforming Growth Factor Beta Signaling, Which Induces Epithelial to Mesenchymal Transition.
    Ebbing EA; Steins A; Fessler E; Stathi P; Lesterhuis WJ; Krishnadath KK; Vermeulen L; Medema JP; Bijlsma MF; van Laarhoven HWM
    Gastroenterology; 2017 Jul; 153(1):63-76.e14. PubMed ID: 28286209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of SPARC Is Associated with Epithelial-Mesenchymal Transition and Low Differentiation State of Biliary Tract Cancer Cells.
    Aghamaliyev U; Gaitantzi H; Thomas M; Simon-Keller K; Gaiser T; Marx A; Yagublu V; Araos J; Cai C; Valous NA; Halama N; Kiesslich T; Ebert M; Grützmann R; Rückert F; Breitkopf-Heinlein K
    Eur Surg Res; 2019; 60(1-2):1-12. PubMed ID: 30650425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-β1/Smad signaling pathway regulates epithelial-to-mesenchymal transition in esophageal squamous cell carcinoma: in vitro and clinical analyses of cell lines and nomadic Kazakh patients from northwest Xinjiang, China.
    Pang L; Li Q; Wei C; Zou H; Li S; Cao W; He J; Zhou Y; Ju X; Lan J; Wei Y; Wang C; Zhao W; Hu J; Jia W; Qi Y; Liu F; Jiang J; Li L; Zhao J; Liang W; Xie J; Li F
    PLoS One; 2014; 9(12):e112300. PubMed ID: 25464508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-β1-induced epithelial-mesenchymal transition in human esophageal squamous cell carcinoma via the PTEN/PI3K signaling pathway.
    Zhang HY; Wang ZQ; Li YY; Wang F; Zeng QR; Gao Y; Xuan XY; Li SS
    Oncol Rep; 2014 Nov; 32(5):2134-42. PubMed ID: 25175594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gremlin1 Delivered by Mesenchymal Stromal Cells Promoted Epithelial-Mesenchymal Transition in Human Esophageal Squamous Cell Carcinoma.
    Hong D; Liu T; Huang W; Liao Y; Wang L; Zhang Z; Chen H; Zhang X; Xiang Q
    Cell Physiol Biochem; 2018; 47(5):1785-1799. PubMed ID: 29953975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secreted Protein Acidic and Rich in Cysteine (SPARC) Enhances Cell Proliferation, Migration, and Epithelial Mesenchymal Transition, and SPARC Expression is Associated with Tumor Grade in Head and Neck Cancer.
    Chang CH; Yen MC; Liao SH; Hsu YL; Lai CS; Chang KP; Hsu YL
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28718842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between secreted protein acidic and rich in cysteine protein expression and the prognosis of postoperative patients exhibiting esophageal squamous cell carcinoma.
    Wu J; Zhang JR; Jiang XQ; Cao XG
    Mol Med Rep; 2017 Sep; 16(3):3401-3406. PubMed ID: 28713937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-130a-3p regulated TGF-β1-induced epithelial-mesenchymal transition depends on SMAD4 in EC-1 cells.
    Tian X; Fei Q; Du M; Zhu H; Ye J; Qian L; Lu Z; Zhang W; Wang Y; Peng F; Chen J; Liu B; Li Q; He X; Yin L
    Cancer Med; 2019 Mar; 8(3):1197-1208. PubMed ID: 30741461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPARC is a key mediator of TGF-β-induced renal cancer metastasis.
    Bao JM; Dang Q; Lin CJ; Lo UG; Feldkoren B; Dang A; Hernandez E; Li F; Panwar V; Lee CF; Cen JJ; Guan B; Margulis V; Kapur P; Brekken RA; Luo JH; Hsieh JT; Tan WL
    J Cell Physiol; 2021 Mar; 236(3):1926-1938. PubMed ID: 32780451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SPARC knockdown attenuated TGF-β1-induced fibrotic effects through Smad2/3 pathways in human pterygium fibroblasts.
    Fan J; Zhang X; Jiang Y; Chen L; Sheng M; Chen Y
    Arch Biochem Biophys; 2021 Nov; 713():109049. PubMed ID: 34624278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dihydromyricetin mediates epithelial mesenchymal transformation and regulates the proliferation and apoptosis of esophageal squamous cell carcinoma cells].
    Tian YP; Cui YS; Zheng X; Liu BL; Zhang YP; Wei KP; Zhang Z; Hu WN; Zhang XM; Sun GG
    Zhonghua Zhong Liu Za Zhi; 2022 Apr; 44(4):326-333. PubMed ID: 35448920
    [No Abstract]   [Full Text] [Related]  

  • 15. Methylation silencing of TGF-β receptor type II is involved in malignant transformation of esophageal squamous cell carcinoma.
    Ma Y; He S; Gao A; Zhang Y; Zhu Q; Wang P; Yang B; Yin H; Li Y; Song J; Yue P; Li M; Zhang D; Liu Y; Wang X; Guo M; Jiao Y
    Clin Epigenetics; 2020 Feb; 12(1):25. PubMed ID: 32046777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of SPARC and TUBB3 as predictors for prognosis in esophageal squamous cell carcinoma receiving nab-paclitaxel plus cisplatin neoadjuvant chemotherapy: a prospective study.
    Gong L; Mao W; Chen Q; Jiang Y; Fan Y
    Cancer Chemother Pharmacol; 2019 Apr; 83(4):639-647. PubMed ID: 30643929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo and in vitro evidence for transforming growth factor-beta1-mediated epithelial to mesenchymal transition in esophageal adenocarcinoma.
    Rees JR; Onwuegbusi BA; Save VE; Alderson D; Fitzgerald RC
    Cancer Res; 2006 Oct; 66(19):9583-90. PubMed ID: 17018615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-β1 upregulates secreted protein acidic and rich in cysteine expression in human granulosa-lutein cells: a potential mechanism for the pathogenesis of ovarian hyperstimulation syndrome.
    Dang X; Fang L; Jia Q; Wu Z; Guo Y; Liu B; Cheng JC; Sun YP
    Cell Commun Signal; 2023 May; 21(1):101. PubMed ID: 37158892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SPARC regulates TGF-beta1-dependent signaling in primary glomerular mesangial cells.
    Francki A; McClure TD; Brekken RA; Motamed K; Murri C; Wang T; Sage EH
    J Cell Biochem; 2004 Apr; 91(5):915-25. PubMed ID: 15034927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programmed death-ligand 1 expression at tumor invasive front is associated with epithelial-mesenchymal transition and poor prognosis in esophageal squamous cell carcinoma.
    Tsutsumi S; Saeki H; Nakashima Y; Ito S; Oki E; Morita M; Oda Y; Okano S; Maehara Y
    Cancer Sci; 2017 Jun; 108(6):1119-1127. PubMed ID: 28294486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.